I
nflammatory bowel disease (IBD) is a chronic inflammatory condition resulting from dysregulated immune response to intestinal microflora in genetically susceptible individuals. 1,2 IBD patients, with Crohn's disease (CD) or ulcerative colitis (UC), often experience a relapsing and remitting clinical course, which can result in significant morbidity and poor quality of life. 3 The cost of IBD care has risen dramatically 4, 5 due to the increasing prevalence of IBD 6, 7 as well as the increasing cost of invasive procedures, surgical interventions, and expensive biological therapies. [8] [9] [10] [11] [12] [13] IBD patient care often requires communication through telephone encounters and email. We recently demonstrated that telephone encounter volume predicted near-term hospital admission, suggesting that telephone encounters can identify patients at risk for medical complications. 14 To further explore the utility of telephone encounters, a noninvasive clinical parameter, we sought to determine the association of telephone encounter activity with financial expenditures. Moreover, we evaluated whether telephone encounter activity could predict future financial spending, distinct from inpatient hospital care.
MATERIALS AND METHODS

Study Cohort
We utilized a prospective, consented, natural history registry of adult (18 y and above) IBD patients maintained at the University of Pittsburgh Medical Center (UPMC). All patients enrolled in the registry having at least 1 clinic visit annually for the years 2009 to 2011 were included. Patients were excluded if they were not enrolled in the registry, did not carry a diagnosis of CD, UC, or IBDunclassified (IBD-U), or did not have an annual clinic visit in 2009 to 2011.
Demographic and Clinical Data
Clinical data for patients enrolled in the registry were systematically exported from the electronic medical record (EMR) through the Center for Assistance in Research using the EMR, an Information Technology support group at UPMC. Data were then organized in a temporal manner. Demographic data included patient characteristics, type of IBD (CD, UC, or IBD-U), duration of disease (years), history of IBD surgeries, disease characteristics according to Montreal Classification, 15 and medical comorbidities derived from ICD-9 code and EMR problem list including psychiatric comorbidity (anxiety and/or depression), hypertension, hyperlipidemia, coronary artery disease, and migraine headaches. Median household income was approximated by zip code (http://www.psc.isr.umich.edu/ dis/census/Features/tract2zip/). Clinical data included annual number of clinic encounters, emergency department (ED) visits, IBD surgeries verified by manual review of operative reports, and hospitalizations. Medication exposures were estimated using outpatient or discharge electronic prescriptions. Prospective measures of disease activity and disease-specific health-related quality of life were measured at every outpatient clinic visit starting in 2009. The Harvey Bradshaw Index 16 (HBI) was used for CD clinical activity metric and the ulcerative colitis activity index (UCAI) for UC. 17 Quality of life was approximated using the IBD-validated Short Inflammatory Bowel Disease Questionnaire (SIBDQ). 18 Total SIBDQ scores range from 10 (poor quality of life) to 70 (excellent quality of life). Mean disease activity indices and SIBDQ were calculated for each calendar year.
Telephone Encounter Data
Patients contacted the clinic via telephone with questions or concerns regarding their care and health status. 14 Telephone encounters were logged into the EMR for the years 2009 to 2011 and exported into the IBD registry. Patients were stratified by quartiles of annual rates of telephone encounters: 0 to 1 telephone encounters per year, 2 to 5 telephone encounters per year, 6 to 10 telephone encounters per year, and >10 telephone encounters per year. Patients were also categorized by cumulative 3-year telephone encounters: 0 to 6 telephone encounters, 7 to 15 telephone encounters, 16 to 25 telephone encounters, and >25 telephone encounters.
Financial Charge Data
Financial charge data for all health care services provided within the UPMC system (20 hospitals and >500 clinics) during 2009 to 2011 was obtained for all IBD registry patients and was manually verified then categorized by inpatient hospital charges, professional service charges for surgery, anesthesia, endoscopy, pathology, radiology, outpatient clinic visits, and other procedures (eg, echocardiogram, bronchoscopy). Charges for laboratories, vaccinations, and gender-specific health care (eg, mammogram) were grouped into a single "other" category. Outpatient medication charges were not included in the charge data obtained. Thus, annual biological therapy charges were imputed based on 2009 to 2011 Medicare maximal allowance data (available at: http://www.cms.gov/Medicare/ Medicare-Fee-for-Service-Part-B-Drugs/McrPartBDrugAvg SalesPrice/index.html) using conservative standard dosing guidelines (infliximab, 5 mg/kg every 8 wk; adalimumab, 40 mg every 2 wk; certolizumab, 400 mg every 4 wk) to approximate mean annual biological cost. If a patient switched biological therapy in a year, then the average cost of the 2 biological therapies was applied to that subject for that year. As it is known telephone encounter activity is predictive of near-term hospitalization, to evaluate financial charges distinct from hospitalizations we excluded inpatient admission charges from further analysis. Telephone encounters do not incur a financial charge, and therefore are not reflected in the charge data. All charges are measured in US dollars and were indexed for base year 2011 by Consumer Price Index (http://www.bls.gov/data/inflation_calcu lator.htm).
Statistical Analyses
Measures of centrality were calculated using mean and SD for normally distributed parameters and median and interquartile range (IQR) for parameters violating normality. Categorical variables were expressed as a proportion. The Fisher exact test was used to assess association for categorical variables. One-way analysis of variance was utilized to test means of normally distributed continuous variables. Kruskal-Wallis and Wilcoxon rank-sum tests were used for nonparametric comparisons. All tests were 2-sided, with statistical significance considered at level P < 0.05.
To determine predictive ability of 2009 telephone activity on future charges, multiple linear regression of natural log-transformed charge values was performed. Natural log-transformed charges were used to maintain normality. Stepwise method of multiple regression was used to determine variables for inclusion into multivariate model. Variables with significance of P < 0.1 in univariate regression were included in final model. Data were analyzed using Stata Statistical Software (Version 13; StataCorp.).
This study was approved by the University of Pittsburgh Institutional Review Board (Protocol# 15050055).
RESULTS
Cumulative Telephone Activity and Patient Demographics (2009 to 2011)
Over the period 2009 to 2011, there were a total of 12,669 phone encounters by 801 patients. There were 254 patients (31.7%) who accumulated between 0 and 6 telephone encounters in the 3-year period, 274 patients (34.2%) between 7 and 15 encounters, 125 patients (15.6%) between 15 and 25 encounters, and 148 patients (18.5%) >25 telephone encounters (Table 1) . Over the 3 years of the study, 20.5% patients remained in the same annual frequency category (10.7% between 0 and 1 encounters annually, 5.5% between 2 and 5 encounters, 1.0% between 6 and 10 encounters, 3.2% >10 encounters), whereas the remaining 79.5% fluctuated in annual frequency category.
High cumulative telephone encounter count (> 25 encounters in 3-y period) was significantly associated with female gender (P = 0.003), history of psychiatric disease (P < 0.001), extensive UC (P = 0.04), and history of IBDrelated surgery (P < 0.001) ( Table 1) . High cumulative telephone users had significantly more ED use (P < 0.001), clinic visits (P < 0.001), hospitalizations (P < 0.001), more IBD-related surgical procedures (P < 0.001), higher disease activity scores (HBI: P < 0.001; UCAI: P < 0.001), worse quality of life (P < 0.001), more corticosteroid (P < 0.001), biological (P < 0.001), and opiate prescriptions (P < 0.001) compared with lower telephone encounter groups over the 3-year study period (Table 2) .
Total Available Financial Charges (2009 to 2011)
The total available financial charges recorded for all patients over the course of the study were $70,513,449. The majority of charges were hospitalization related (67.8%) (Fig. 1) . After exclusion of hospitalization charges, the major contributors to charges were biological medications (39.7%), surgery (19.3%), and endoscopy including pathology (18.7%). 
Telephone Encounter Frequency and Financial Charges (2009 to 2011)
Patients with more telephone encounters from 2009 to 2011 incurred higher median total available health care expenditures over the course of the study (P < 0.001) ( Fig. 2A) . Patients with >25 telephone encounters had a median cumulative charge of $37,882 (IQR, $58,690) for the years 2009 to 2011 compared with $28,265 (IQR, $40,742) for 16 to 25 encounters, $11,557 (IQR, $22,760) for 7 to 15 encounters, and $6705 (IQR, $12,554) for 0 to 6 telephone encounters. Furthermore, patients who logged >25 cumulative telephone encounters from 2009 to 2011 had significantly higher median total available annual charges for each year compared with patients with fewer telephone encounters (P < 0.001 for all years) over the study period (Fig. 2B) .
Telephone Encounter Rate and Future Charges
Increased telephone encounter count in 2009 was associated with significantly increased median cumulative 3-year charges (P < 0.001) (Fig. 3A) . In addition, patients calling >10 times in 2009 had significantly increased median total available expenditures in both 2010 and 2011 (both P < 0.001) (Fig. 3B) . Furthermore, these patients had significantly increased spending in biological medications, surgery, endoscopy and pathology, outpatient clinic visits, as well as procedures and radiology in 2010 compared with patients with fewer than 10 telephone encounters in 2009 (all P < 0.01) (Fig. 4A) . These significant differences in charges based on 2009 telephone encounter rates extended into 2011 expenditures as well (all P < 0.01) (Fig. 4B ). These findings were replicated when examining 2010 telephone encounter counts and 2011 financial charge categories (all P < 0.01) (Fig. 4C) .
Multiple linear regression of financial charges controlling for significant demographic, medication, and health care utilization covariates demonstrated that telephone encounter category in 2009 was significantly predictive of total available expenditures in 2010 (P = 0.02) and 2011 (P = 0.04) (Appendix Tables 1 and 2 , Supplemental Digital Content 1, http://links.lww.com/JCG/A309). Similarly, telephone encounter category in 2010 was significantly predictive of total available charges in 2011 (P = 0.001).
Persistently High Telephone Encounters Population
From 2009 to 2011, 26 patients (3.2%) remained in the high telephone encounter (> 10 encounters) category each year. In this group, 69.2% were female with a mean age of 38.1 ± 12.7 years, and 65.4% had a history of depression and/or anxiety (Appendix Table 3 , Supplemental Digital Content 2, http://links.lww.com/JCG/A310). Most patients (80.8%) had CD. Patients in the persistently high telephone encounter grouping had a significantly lower quality of life (median SIBDQ, 40.5 vs. 54.0; P < 0.001), higher proportion of ED use (73.1% vs. 30.7%; P < 0.001), hospitalization (61.5% vs. 35.9%; P = 0.01), and more aggressive medical management (corticosteroids, 76.9% vs.
37.0%; P < 0.001 and biological, 53.8% vs. 26.2%; P = 0.003) compared with patients who had fewer telephone encounters.
The persistently high telephone encounter group of 26 patients (3.2%) accounted for $1,948,675 (9.2%) of total available charges from 2009 to 2011. The majority of the health care charges resulted from biological agents (35.1%), surgery (19.3%), and endoscopy and pathology (18.2%).
DISCUSSION
In this 3-year prospective study, we demonstrate that patients with increased telephone encounter volume accrue significantly higher health care financial charges. Furthermore, telephone encounter volume can predict future health care spending in the following years. Together these findings suggest that telephone encounter monitoring can identify patients for targeted intervention.
Telephone communication between patients and providers is essential to modern medical care, and is particularly important to the management of chronic illness. 19, 20 Patients call providers for a variety of reasons from clinical symptoms, medication refills, or questions. Telephone encounters logged in the EMR are a noninvasive measure of patient activity. In this study, patients with high telephone encounters had higher rates of severe disease, health care utilization, aggressive medical therapy, and worse quality of life.
Relatively few studies have examined telephone call data in chronic illness and how it relates to patient phenotype. In the current study, patients with increased telephone encounter volume had significantly higher rates of anxiety and/or depression. Characterization of highfrequency telephone callers in patients with Parkinson's disease, 21 a specialty headache clinic, 22 an epilepsy hotline, 23 and general counseling service 24 have demonstrated similar association with mental health comorbidities and telephone activity. Furthermore, we identified a small proportion of patients who have persistently high telephone activity and who contributed disproportionately to expenditures. Over half of the patients in this subgroup had comorbid depression and pain (prescription opiate use). This may suggest impaired coping ability in this patient population and potential benefit from IBD coping and mental health interventions. 25 This analysis also determined the majority (68%) of available health care expenses resulted from hospitalization, which correlates with prior studies. 8, 9, 13, 26 Prior work from our group demonstrated the high telephone activity was associated with increased risk of near-term hospitalization. 14 In the current study, even after exclusion of inpatient-related charges, patients with higher telephone encounter activity had significantly increased financial charges. Telephone activity was also predictive of future spending after controlling for significant demographic, utilization, and medication factors. These findings suggest telephone activity may function as a low cost and noninvasive way to monitor IBD patients and selectively target patients for interventions.
There are several limitations to this study. This study was conducted in a tertiary referral IBD center and thus this study sample may not be representative of other IBD populations. Information bias is also of concern as we were dependent on EMR logging for telephone encounters and inappropriate or absent logging would result in skewed data and misclassification. In addition, this study did not include alternative methods of patient-provider communication such as email or online EMR patient portal contact. During the time period of the study, enrollment in the EMR online patient portal was not mandatory and was infrequently utilized. Thus, inclusion of these data would have introduced significant enrollment and information biases. Financial charge data were used in this study at a single institution and charges vary widely by hospital, institution, and geographic location. Thus, the exact charge values in this study may not be representative of other hospital centers. In addition, as the charges stemmed from within health care system utilization only, outside sources of health care and their ensuing charges were not accounted for in this study. We attempted to limit this impact by only including patients with at least 1 annual outpatient clinic visit, ensuring some degree of care continuity. Biological costs were imputed in this analysis and thus the impact of other medical therapies was not measured. We utilized this approach as biologicals are overwhelmingly responsible for the majority of annual medication charges in IBD patients. We used financial charges as opposed to cost data to limit the influence of insurance status (ie, insured population sees little to no cost as a result of insurance coverage). Conversely, uninsured patients may amass larger than normal health care services as a result of limited access to outpatient care and delayed care. We did not observe any association of insurance coverage to telephone activity. Lastly, health care financial charges are not directly translatable to costs as traditionally perceived from a payer or societal perspective due to insurance adjustments, deductibles, and rebates. However, it is conceivable that higher health care charges are likely to translate into higher costs compared with lower charges, even after claims or adjustments.
There are several strengths to this study. It was performed using prospectively collected data on a large cohort of IBD patients, without a change in patient behavior as a result of enrollment or recall bias, and thus accurately reflects pattern of disease and patient activity. Financial charges in this study were for all available health care expenses, including nongastrointestinal illness. This is a strength as IBD affects not only in the gastrointestinal tract, but also psychological well-being, 27, 28 bone and nutritional health, [29] [30] [31] [32] [33] hematologic profiles, 34, 35 and rheumatologic processes. [36] [37] [38] All-inclusive financial charges capture all relevant effects.
Telephone encounters represent a universal, noninvasive marker that can be tracked at other institutions with limited additional training, personnel, or cost. Most importantly, early identification of at-risk patients can provide a mechanism for implementing strategies to prevent costly future health care utilization.
In conclusion, telephone encounters represent a marker of at-risk patients for high health care expenditures. Telephone encounters represent a novel disease phenotype that accurately identifies high-utilization patients. Prospective interventional studies targeted at patients with high telephone encounter frequency should be considered to determine whether the cost of IBD care could be reduced.
